Array BioPharma Inc. (ARRY) - Buy, Sell or Hold?
Sector: Consumer Durables Sub-Sector: Major Pharmaceuticals
| Trade Date | Current Candlestick Pattern | Previous Candlestick Pattern | When | Performance Since |
|---|---|---|---|---|
| Tue, 28 Nov 2017 | None | Bullish Engulfing | Wed, 22 Nov 2017 | 0.71% |
| ***Stock database and scans are updated around midnight (New York time) every trading day. | ||||
11.41 0.00 (0%) Nov 28 4:00pm EDT
Open: 11.49 Range: 11.15 - 11.50 Vol: 2.15M Avg Vol: 4.23M
Analyze "ARRY" - FREE 30 Day Trial of Market Analyst 7
Short Term: Trend is Up
Last Trade is above the 5 day moving average at 11.38
Medium Term: Trading is Range Bound
Last Trade is above the 20 day moving average at 11.08
Last Trade is below the 50 day moving average at 11.44
Long Term: Trend is Up
Last Trade is above the 200 day moving average at 9.59
* Data normalized for Splits & Dividends. Report data issues
How to use this info: Stock Timing With Moving Averages
How to use this info: Stock Timing With Moving Averages
News on "ARRY" Stock
- Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates
- Wired News - NCCN Recommends BRAFTOVI with MEKTOVI as Category 1 Treatment Option for BRAF-Mutant Melanoma
- See what the IHS Markit Score report has to say about Array Biopharma Inc.
- The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
- Array Biopharma Fell, FDA Approval for Melanoma Drug Yesterday
| Consumer Durables Stocks Above 200 Day Moving-Average | |||
|---|---|---|---|
| Ticker | Name | Trend Analysis | Support/Resistance |
| EDUC | Educational Development Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| CRMT | America's Car-Mart, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| NEPT | Neptune Technologies & Bioresources Inc | Buy, Sell or Hold | Trading Levels & Pivots |
| PRGO | Perrigo Company | Buy, Sell or Hold | Trading Levels & Pivots |
| SCHN | Schnitzer Steel Industries, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| CYCCP | Cyclacel Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| RIGL | Rigel Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| SCMP | Sucampo Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| POOL | Pool Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| SNSS | Sunesis Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
Stock Trend Analysis - Buy, Sell or Hold "Array BioPharma Inc." (ARRY)?
ARRY is in a very strong uptrend. In the last 52 weeks, ARRY has been trading above the 200 day moving average for 81% of the time with an average daily volume of 4.2M shares being traded. The 50 day moving average, currently at 11.44, although still maintaining a bullish inclination, is however exhibiting characteristics of a medium term trading range. As the dominant long term trend is still up strongly, the high probability trade is still buying the dips. The 20 day moving average, although in a trading range, generally confirms this view as the underlying strength in ARRY still has a bullish bias with price maintaining above the 20 SMA for 52.5% of the time in the last two months of trading. A good area for traders who are considering taking a long position in ARRY is near the 200 SMA currently at 9.59. Click here for the latest support & resistance levels to help you finetune your entry into or exit out of "ARRY".The analyst consensus estimates for the 1 year price target for this stock is $15.00* (*source: Yahoo Finance).